Flipped out: Structure-guided design of selective pyrazolylpyrrole ERK inhibitors

被引：111

作者：

Aronov, Alex M. ^{[1
]}

Baker, Christopher ^{[1
]}

Bemis, Guy W. ^{[1
]}

Cao, Jingrong ^{[1
]}

Chen, Guanjing ^{[1
]}

Ford, Pamella J. ^{[1
]}

Germann, Ursula A. ^{[1
]}

Green, Jeremy ^{[1
]}

Hale, Michael R. ^{[1
]}

Jacobs, Marc ^{[1
]}

Janetka, James W. ^{[1
]}

Maltais, Francois ^{[1
]}

Martinez-Botella, Gabriel ^{[1
]}

Namchuk, Mark N. ^{[1
]}

Straub, Judy ^{[1
]}

Tang, Qing ^{[1
]}

Xie, Xiaoling ^{[1
]}

机构：

[1] Vertex Pharmaceut Inc, Cambridge, MA 02139 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2007年 / 50卷 / 06期

关键词：

D O I：

10.1021/jm061381f

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The Ras/Raf/MEK/ERK signal transduction is a key oncogenic pathway implicated in a variety of human cancers. We have identified a novel series of pyrazolylpyrroles as inhibitors of ERK. Aided by the discovery of two distinct binding modes for the pyrazolylpyrrole scaffold, structure-guided optimization culminated in the discovery of 6p, a potent and selective inhibitor of ERK.

引用

页码：1280 / 1287

页数：8

共 26 条

[1] A novel mode of Gleevec binding is revealed by the structure of spleen tyrosine kinase
Atwell, S
Adams, JM
Badger, J
Buchanan, MD
Feil, IK
Froning, KJ
Gao, X
Hendle, J
Keegan, K
Leon, BC
Müller-Dieckmann, HJ
Nienaber, VL
Noland, BW
Post, K
Rajashankar, KR
Ramos, A
Russell, M
Burley, SK
Buchanan, SG
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (53) : 55827 - 55832
[2] BOS JL, 1989, CANCER RES, V49, P4682
[3] Chang FM, 2003, INT J ONCOL, V22, P469
[4] The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation
Cowan-Jacob, SW
Fendrich, G
Manley, PW
Jahnke, W
Fabbro, D
Liebetanz, J
Meyer, T
[J]. STRUCTURE, 2005, 13 (06) : 861 - 871
[5] CONVERSION OF CHIRAL AMINO-ACIDS TO ENANTIOMERICALLY PURE ALPHA-METHYLAMINES
DONNER, BG
[J]. TETRAHEDRON LETTERS, 1995, 36 (08) : 1223 - 1226
[6] OXIDATIVE PREPARATION OF OPTICALLY-ACTIVE N-HYDROXY-ALPHA-AMINO ACID-AMIDES
FEENSTRA, RW
STOKKINGREEF, EHM
REICHWEIN, AM
LOUSBERG, WBH
OTTENHEIJM, HCJ
KAMPHUIS, J
BOESTEN, WHJ
SCHOEMAKER, HE
MEIJER, EM
[J]. TETRAHEDRON, 1990, 46 (05) : 1745 - 1756
[7] HALE M, 2003, Patent No. 03011855
[8] TOTAL SYNTHESIS OF (+/-)-VALLESAMIDINE
HEATHCOCK, CH
NORMAN, MH
DICKMAN, DA
[J]. JOURNAL OF ORGANIC CHEMISTRY, 1990, 55 (03) : 798 - 811
[9] The Ras-Raf-MEK-ERK pathway in the treatment of cancer
Hilger, RA
Scheulen, ME
Strumberg, D
[J]. ONKOLOGIE, 2002, 25 (06): : 511 - 518
[10] ERBB receptors and cancer: The complexity of targeted inhibitors
Hynes, NE
Lane, HA
[J]. NATURE REVIEWS CANCER, 2005, 5 (05) : 341 - 354

← 1 2 3 →